LRRK2 and Parkinson disease: In contrast, a recent large screening study on 8301 North American patients reported 272 (3.3%) individuals with monogenic PD genotypes (including only disease-causing variants), which was largely driven by 196 (2.4%) carriers of LRRK2 variants, mostly p.(Gly2019Ser) [36].